Research Professor Akseli Hemminki presents on the present and future of oncolytic virus therapies at Docrates Clinic
Research Professor Akseli Hemminki presented on February 23, 2010, for a group of oncologists, patients and other interest parties on oncolytic virus therapies at Docrates Clinic. His presentation covers both science and clinical results achieved by the industry – until today and what is to be expected in the future. Especially, the presentation focuses on the CGTG-102 virus, the lead candidate of Oncos Therapeutics, and how it has already helped and continues to help patients in the Advanced Therapy Access Program.
